Role of bacteria in the pathogenesis and progression of acute and chronic lung infection R A Stockley
The lung presents a major interface between the much of our understanding of pathogenesis is based upon in vitro studies utilising pure external environment and the body. Although cytokines and studying their effects. In vivo antigens, including viable bacteria, are inhaled the situation may be much more complex, on a regular basis, health is maintained and particularly since a "cocktail" of cytokines is the organisms are excluded by a multitude released at the same time, some of which have of sophisticated and complex host defence diametrically opposed effects in vitro. Nevermechanisms. These include the integrity of the theless, with this as a background it is possible bronchial epithelium and the efficiency of the to derive some concepts of the processes inmucociliary escalator which prevents bacterial volved and some of the mediators that may be adherence and penetration whilst at the same relevant. time facilitating their removal. In addition, the lung secretions contain various proteins including lysozyme and lactoferrin which prevent bacterial replication, as well as immunoglobulin Studies in man A which prevents bacterial adhesion and scav-The importance of the primary and secondary enging phagocytic cells to destroy the bacteria host defence in the relationship between the that remain.
lung and bacteria can only be determined by The relationship between the lung and bacindirect observations. Genetic disorders of teria can take on several abstract forms: (a) a mucociliary clearance (the major primary host transient relationship where the host remains defence) are known to be associated with the intact, the bacterial load remains low, and the development and progression of chronic lung primary lung defences outlined above result infection. In addition, systemic immune dein effective clearance; (b) acute infections ficiency and disorders of neutrophil function where the bacterial load is higher, the local (secondary host defence factors) are also asdefences fail to cope, and bacterial numbers sociated with persistent recurrent infections. increase. At this point an acute inflammatory These defects clearly emphasise the importance process occurs leading to the recruitment of of host defence. However, most patients with the secondary lung defence systems including both acute and chronic infections do not appear scavenging neutrophils. The patient becomes to have any major defect of host defence that acutely unwell and the inflammatory response has yet been identified. 3 4 results in sterilisation of the bronchial tree and the infective process resolves; (c) colonisation: this usually occurs on the background of ab- / normal host defence. The process is low grade This is a systemic illness in which the primary with a mild degree of inflammation and a ballung defence has been overcome by the inhaled ance is established between the local host debacteria. Secondary host defence mechanisms fence mechanisms and bacterial replication to are activated with neutrophil infiltration and achieve a position of stability. This situation inflammation develops within the lung. These may be associated with recurrent acute exepisodes are usually short lived and may be acerbations which are self-limiting and resolve; either fatal, self-limiting, or curtailed by the and (d) chronic infection: in this situation the use of the appropriate antibiotic therapy. bacterial load is sufficient to generate a marked
The process of acute infection should theinflammatory response that fails to clear the oretically go through several stages. Once the organism. It can become self-perpetuating and inflammatory process has started there is likely lead to the development of chronic progressive to be an amplification stage which will result bronchial disease. 1 in either sufficient or insufficient recruitment
Initiation
The initiation of the infective process occurs when sufficient bacteria are present in the lung and overcome the ability of local host defences to clear them. This may simply involve the inhalation of sufficient bacteria in the first instance, or may be potentiated by the release of various bacterial factors that interfere with host defences such as pyocyanin and hydroxyphenazine which significantly reduce mucociliary clearance, 5 lipopolysaccharide which damages epithelium, 6 or IgA proteases 7 which damage secretory IgA and therefore may facilitate bacterial adherence to the epithelium. At this point the inflammatory process is initiated. Evidence has shown that bacteria possess the ability to stimulate human bronchial epithelial cells to produce a variety of cytokines some of which may be pro-inflammatory. Of major importance is thought to be the chemoattractant interleukin 8 (IL-8) and tumour necrosis factor (TNF-). 8 Epithelial IL-8 is a major neutrophil chemoattractant and, once released from the bronchial epithelium, it forms a diffusion gradient into the circulation attracting and activating nearby leucocytes. The process of neutrophil migration will be further enhanced by stimulation of endothelial cell adhesion molecules and, although some of these are constitutionally expressed on the endothelium, the release of pro-inflammatory cytokines such as TNF-will increase the expression of these molecules 9 and facilitate neutrophil adhesion.
Amplification
The recruitment of neutrophils to the airways may actually facilitate the amplification process. Activation of neutrophils has been shown to release both LTB 4 10 and IL-8 11 which will add to the chemoattractant concentration in the airway and potentiate the diffusion gradient into the circulation. In addition, release of neutrophil elastase as the neutrophil becomes activated has also been shown to increase epithelial cell IL-8 production, 12 again adding to the chemoattractant gradient. phase (the contribution to IL-8 and TNF pro-
In addition the inflammatory response results in an increase in proteinase inhibitors such duction). This in itself will reduce the drive to as 1 -antitrypsin in the airway which can inactivate the elastase and thereby all of its effects on host defences and epithelial tissues. As the drive to neutrophil recruitment and neutrophil recruitment. As fewer neutrophils the loss of epithelial damaging factors decreases, epithelial repair can take place.
are recruited and activated they will generate less IL-8 and LTB 4 in their own right, as well as less neutrophil elastase to promote IL-8 production by the epithelial cell. This change in conjunction with host defences results in bacterial destruction and subsequent res-in itself may be sufficient to switch off the inflammatory process but may be facilitated by olution. These simple steps of initiation, amplification and resolution are outlined in fig 1. the generation of anti-inflammatory cytokines.
group.bmj.com on June 27, 2017 -Published by http://thorax.bmj.com/ Downloaded from At this point the acute phase response may ml) plus a small number of recruited neutrophils and detectable plasma protein tran-also be important. Alpha-1-antitrypsin undergoes a 3-4-fold rise in serum concentrations sudation into the secretions. Nevertheless, this represents virtually a symbiotic relationship. during episodes of systemic inflammation. This, coupled with the increase in lung endo-The bacteria isolated are usually those considered to be of low pathogenicity (Haemophilus thelial and epithelial permeability that occurs during infection, should result in a major in-influenzae, Moraxella catarrhalis, Haemophilus parainfluenzae) and may themselves facilitate crease in the diffusion of this proteinase inhibitor into the lung. The effect would be to this whole process by interfering with several mechanisms of host defence. For instance, bac-limit the amount of active neutrophil elastase within the lung tissue and it may therefore terial products have been shown to interfere with neutrophil chemotactic responses 16 and serve as a mechanism for downregulating the inflammatory response being driven by the re-may therefore downregulate an important mechanism that would lead to sterilisation of lease of this enzyme. In addition, one of the other acute phase proteins, 1 -anti-the bronchial tree. In addition, bacteria have been shown to have a major effect on factors chymotrypsin, has been shown to be a major inhibitor of neutrophil chemotaxis. 13 Again, the involved in mucociliary clearance. Cilia toxins have been shown to be produced by a variety of concentration of this protein rises dramatically during inflammation (several fold within 12 bacteria which colonise the airways in patients with chronic bronchial disease. In addition, hours). The effect of this also could limit neutrophil traffic into the lung and thereby bacteria can lead to excess mucus production in their own right 17 and will therefore lead downgrade the inflammatory process.
Finally, during the process of resolution, apo-to chronic bronchitis. Bacterial products can cause epithelial damage 6 which will facilitate ptosis of the recruited neutrophils may be an important mechanism. How this takes place bacterial adherence and again lead to a reduction in their clearance. Finally, pathogenic and its relationship to the initiation of the inflammatory process is difficult to discern. bacteria are known to produce IgA proteases 7 which may therefore interfere with the ability TNF-has been shown to increase apoptosis in vitro 14 and may therefore be important in of IgA to prevent bacterial adherence, again a process that would facilitate bacterial per-the resolution of inflammation. However, as indicated above, the same cytokines may ac-sistence in the airways.
It is possible that the process itself may be tually accentuate the inflammatory process by the stimulation of endothelial cell adhesion perpetuated by host immune defects. As indicated at the beginning of this article, major molecules. Furthermore, activation of neutrophils by endotoxin can prevent the effect of defects of immunity are associated with persistent and/or recurrent bacterial infections. TNF on apoptosis. 14 Thus, changes in the biochemical environment in the airway may However, most patients with chronic bronchial disease do not have a clearly identifiable im-affect the way the neutrophil responds to single or multiple factors. Similarly, studies have mune defect. Nevertheless, there are studies which suggest that in some patients the immune shown that IL-6 is also capable of promoting apoptosis 15 and yet studies by Khair and col-response may be abnormal, resulting in the production of the wrong type of antibody that leagues have indicated that IL-6 is released at the same time as pro-inflammatory cytokines does not facilitate bacterial phagocytosis and clearance but rather acts as a blocking antibody, from bronchial epithelium exposed to endotoxin from Haemophilus influenzae. 8 The ra-"protecting" the bacteria from normal clearance mechanisms. 18 tionalisation of these diverse properties and their relationship to the initiation and reso-In addition, recent studies have suggested that the bacteria may be able to facilitate their lution of inflammation remains to be achieved.
survival by continually changing their antigenic nature to remain ahead of a host immune response. 19 The importance of this mechanism  Colonisation represents a state between acute in the persistence of bacteria in the airways of patients with bronchial disease and the initi-infection and complete resolution. It is generally associated with an identified breach in ation of acute exacerbations of chronic bronchitis is clearly worthy of further study. host defences and usually this is because of a defect in mucociliary clearance related to ciliary dysfunction, epithelial destruction, or abnormal mucus production. A failure of this  
Chronic bronchial infection appears to be as-important mechanism of clearance would, firstly, delay removal of bacteria from the lung sociated with an overactive response of the immune system (which may indeed be in-and, secondly, provide a suitable culture medium for bacterial replication. Chronic col-appropriate) and the perpetuation of the inflammatory response. Studies have shown that onisation therefore reflects a state in which bacterial replication keeps pace with the prim-such patients often have increased circulating immunoglobulin levels and increased immuno-ary host defence clearance mechanisms.
There may be a low grade inflammatory globulins in the secretions. 4 The lung tissues contain increased numbers of immunoglobulin process in patients with chronic bronchitis and emphysema in the stable clinical state. The generating B cells, 20 particularly the IgA 1 and IgA 2 subclasses. 21 In addition, the T cell popu-patients may often have a significant bacterial load in their secretions (10 8 viable organisms/ lation is increased with the greatest increase group.bmj.com on June 27, 2017 -Published by http://thorax.bmj.com/ Downloaded from herence), damage to immunoglobulins (preventing opsonisation), and even destruction of phagocytic receptors on the neutrophil itself (reducing opsonophagocytosis). This sequence of events has led to the concept of neutrophil mediated progression of chronic bronchial disease and persistence of chronic infection. 1 As intimated above, the process can often be reversed by the use of appropriate antibiotics. However, such responses are usually short lived and patients may require long term antibiotic therapy in order to downregulate the inflammatory process and prevent persistent bronchial disease. In some instances this process may be permanently reversed, such that withdrawal of antibiotic therapy after a period of time may not be associated with an immediate return to the chronic infective state (fig 2) .
In conclusion, bacteria play a role in initiating the processes involved in both acute and chronic lung infection. The former are usually short lived episodes which generally result in resolution and the return to a state of health. In the latter case the infective process, although relatively confined to the lung, may persist and be associated with processes that perpetuate and in most severe cases be related to progression of the chronic lung disease. 
